Charleston Pharma, based in Charleston, SC, is a pioneering biotech company specializing in the development of anti-nucleolin antibodies with potential widespread clinical utility.
Their lead IgG1 monoclonal antibody CP101.2C8 targets the nucleolin transporter on tumor cells, inducing apoptosis and cell death in various hematological and solid tumor cell lines by destabilizing multiple oncogenic mRNAs.
Generated from the website